Hubert Serve

39PUBLICATIONS
239CO-AUTHORS
Molecular targetsHaematological tumoursHaematologyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 08, 2026
USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemia.

|Apr 14, 2026
Inhibition of high CXCR4 with motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Enise Ceran, Sonia Jaramillo, Anne Kathrin Merbach

|Apr 06, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

Eva Rettinger, Dirk Heckl, Martin Hutter

|Dec 08, 2025
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.

Anne Sophie Platzbecker, Julia-Annabell Georgi, Jan Moritz Middeke

|Aug 18, 2025
Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Uwe Platzbecker, Lionel Adès, Pau Montesinos

|Aug 01, 2025
Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells.

Cornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank

Pageof 7

Frequent Collaborators

15 joint publications

Christoph Röllig

14 joint publications

Carsten Müller-Tidow

12 joint publications

Martin Bornhäuser

10 joint publications

Christian Thiede